Abstract
Patients who have cardiac arrhythmias are also likely to have coexistent cardiovascular disease, such as ischemic heart disease, hypertension, or congestive heart failure. Such patients often take other cardiovascular drugs in addition to antiarrhythmic drugs to treat these problems. Because cardiac arrhythmias more commonly occur in the elderly, patients who take antiarrhythmic drugs are likely to be taking one or more noncardiovascular drugs as well. Thus, the risk of drug-drug interactions in this population is potentially great. This articlefocuses on the potentially drug-drug interactions that may occur with the broad-spectrum antiarrhythmic agent procainamide.
| Original language | English |
|---|---|
| Pages (from-to) | 53-60 |
| Number of pages | 8 |
| Journal | Geriatric Medicine Today |
| Volume | 9 |
| Issue number | 5 |
| State | Published - 1990 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Geriatrics and Gerontology
Cite this
Drug interactions with an antiarrhythmic agent. / Hilleman, Daniel E.
In: Geriatric Medicine Today, Vol. 9, No. 5, 1990, p. 53-60.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Drug interactions with an antiarrhythmic agent
AU - Hilleman, Daniel E.
PY - 1990
Y1 - 1990
N2 - Patients who have cardiac arrhythmias are also likely to have coexistent cardiovascular disease, such as ischemic heart disease, hypertension, or congestive heart failure. Such patients often take other cardiovascular drugs in addition to antiarrhythmic drugs to treat these problems. Because cardiac arrhythmias more commonly occur in the elderly, patients who take antiarrhythmic drugs are likely to be taking one or more noncardiovascular drugs as well. Thus, the risk of drug-drug interactions in this population is potentially great. This articlefocuses on the potentially drug-drug interactions that may occur with the broad-spectrum antiarrhythmic agent procainamide.
AB - Patients who have cardiac arrhythmias are also likely to have coexistent cardiovascular disease, such as ischemic heart disease, hypertension, or congestive heart failure. Such patients often take other cardiovascular drugs in addition to antiarrhythmic drugs to treat these problems. Because cardiac arrhythmias more commonly occur in the elderly, patients who take antiarrhythmic drugs are likely to be taking one or more noncardiovascular drugs as well. Thus, the risk of drug-drug interactions in this population is potentially great. This articlefocuses on the potentially drug-drug interactions that may occur with the broad-spectrum antiarrhythmic agent procainamide.
UR - http://www.scopus.com/inward/record.url?scp=0025287366&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025287366&partnerID=8YFLogxK
M3 - Article
VL - 9
SP - 53
EP - 60
JO - Geriatric Medicine Today
JF - Geriatric Medicine Today
SN - 0745-1709
IS - 5
ER -